Cargando…
Development of vaccines against Crimean-Congo haemorrhagic fever virus
Crimean-Congo haemorrhagic fever virus (CCHFV) is a deadly human pathogen of the utmost seriousness being highly lethal causing devastating disease symptoms that result in intense and prolonged suffering to those infected. During the past 40 years, this virus has repeatedly caused sporadic outbreaks...
Autores principales: | Dowall, Stuart D., Carroll, Miles W., Hewson, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637709/ https://www.ncbi.nlm.nih.gov/pubmed/28687403 http://dx.doi.org/10.1016/j.vaccine.2017.05.031 |
Ejemplares similares
-
A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model
por: Buttigieg, Karen R., et al.
Publicado: (2014) -
Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses
por: Dowall, Stuart D., et al.
Publicado: (2016) -
Crimean–Congo haemorrhagic fever virus
por: Hawman, David W., et al.
Publicado: (2023) -
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model
por: Saunders, Jack E., et al.
Publicado: (2023) -
Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of Borno State, Northeastern Nigeria
por: Bukbuk, David N., et al.
Publicado: (2016)